Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol sedation for hysteroscopy
ChiCTR2300068576Phase 4Not yet recruiting
- Sponsor
- Hangzhou Women's Hospital
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in Endometrial lesion (2 arms), sponsored by Hangzhou Women's Hospital. Primary endpoints: Onset time, Awakening time and 1 more. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Endometrial lesion
Beyond the preview
Go deeper on ChiCTR2300068576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068576.